| Field | Row 1 |
|---|---|
| adsh | 0001999371-25-005991 |
| cik | 883107 |
| name | SOLESENCE, INC. |
| sic | 2844 |
| countryba | US |
| stprba | IL |
| cityba | ROMEOVILLE |
| zipba | 60446 |
| bas1 | 1319 MARQUETTE DRIVE |
| bas2 | |
| baph | 6307716078 |
| countryma | US |
| stprma | IL |
| cityma | ROMEOVILLE |
| zipma | 60446 |
| mas1 | 1319 MARQUETTE DRIVE |
| mas2 | |
| countryinc | US |
| stprinc | DE |
| ein | 363687863 |
| former | NANOPHASE TECHNOLOGIES CORP |
| changed | 20160208 |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250513 |
| accepted | 2025-05-13 17:30:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | sol-10q_033125_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001999371-25-005991 | 20250331 | Accrued Liabilities Current | 5266000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20231231 | Accounts Receivable Net Current | 3467000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Assets | 57016000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Assets Current | 35904000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1722000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Common Stock Shares Outstanding | 70103279.0000 | shares | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Deferred Revenue Current | 4622000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Depreciation Depletion And Amortization | 234000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Increase Decrease In Deferred Revenue | 239000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Increase Decrease In Operating Lease Liability | -322000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Liabilities Current | 32876000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Lines Of Credit Inventory Current | 5200000.0000 | USD | 0 | 0001999371-25-005991 | |||
| 0001999371-25-005991 | 20250331 | Net Cash Provided By Used In Financing Activities | 7496000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Operating Lease Liability Current | 1260000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Other Assets Noncurrent | 3000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Payments For Proceeds From Productive Assets | 85000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Payments For Proceeds From Productive Assets | -133000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240229 | Proceeds From Issuance Of Convertible Preferred Stock | 6000000.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Series X Preferred Stock; | ||
| 0001999371-25-005991 | 20240331 | Repayments Of Related Party Debt | 1960000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 1376000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Personal Care Ingredients; | ||
| 0001999371-25-005991 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 9772000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Product; | ||
| 0001999371-25-005991 | 20250331 | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | 100000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | 100000.0000 | USD | 1 | us-gaap/2025 | Property Plant And Equipment By Type= Trucks; | ||
| 0001999371-25-005991 | 20231231 | Stockholders Equity | -104663000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001999371-25-005991 | 20250331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001999371-25-005991 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 52675851.0000 | shares | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Inventory Net | 21912000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Accounts Payable Current | 9168000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Accounts Receivable Gross Current | 5655000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Asset Retirement Obligations Noncurrent | 246000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1817000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Common Stock Shares Outstanding | 70103279.0000 | shares | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Common Stock Value | 700000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Cost Of Goods And Services Sold | 6288000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Earnings Per Share Diluted | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Increase Decrease In Operating Lease Liability | -53000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Interest Expense Nonoperating | 176000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Operating Income Loss | 256000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Preferred Stock Value | USD | 0 | us-gaap/2025 | ||||
| 0001999371-25-005991 | 20250331 | Proceeds From Issuance Of Convertible Preferred Stock | USD | 1 | us-gaap/2025 | ||||
| 0001999371-25-005991 | 20250331 | Property Plant And Equipment Net | 13105000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 14625000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 12882000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Consumer Products; | ||
| 0001999371-25-005991 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 1373000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Personal Care Ingredients; | ||
| 0001999371-25-005991 | 20231231 | Shares Outstanding | 49627254.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001999371-25-005991 | 20231231 | Stockholders Equity | 496000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001999371-25-005991 | 20240331 | Stockholders Equity | -103770000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001999371-25-005991 | 20241231 | Stockholders Equity | 114674000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001999371-25-005991 | 20250331 | Stockholders Equity | 114804000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001999371-25-005991 | 20240331 | Stock Issued During Period Shares New Issues | 5233730.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001999371-25-005991 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 72632116.0000 | shares | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Net Income Loss | 80000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 160000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 160000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001999371-25-005991 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 127000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001999371-25-005991 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001999371-25-005991 | 20250331 | Allowance For Doubtful Accounts Receivable Current | 999000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Capital Expenditures Incurred But Not Yet Paid | 286000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Cash And Cash Equivalents At Carrying Value | 1817000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1409000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Common Stock Shares Authorized | 95000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Cost Of Goods And Services Sold | 11243000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Earnings Per Share Basic | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Gross Profit | 3580000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Increase Decrease In Accounts Receivable | 4216000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 287000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Lines Of Credit Current | USD | 0 | us-gaap/2025 | ||||
| 0001999371-25-005991 | 20250331 | Lines Of Credit Current | 6292000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Net Cash Provided By Used In Investing Activities | -85000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Net Cash Provided By Used In Investing Activities | 133000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Operating Income Loss | 1111000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Operating Lease Right Of Use Asset | 8006000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Prepaid Expense And Other Assets Current | 2803000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Proceeds From Issuance Of Common Stock | 1996000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Proceeds From Other Short Term Debt | 6292000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Research And Development Expense | 1018000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 50000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Product And Service Other; | ||
| 0001999371-25-005991 | 20241231 | Shares Outstanding | shares | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | |||
| 0001999371-25-005991 | 20241231 | Stockholders Equity | 700000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001999371-25-005991 | 20241231 | Stockholders Equity | USD | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | |||
| 0001999371-25-005991 | 20241231 | Operating Lease Right Of Use Asset | 7917000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Accounts Payable Current | 9093000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Additional Paid In Capital | 114804000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 127000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2025 | Equity Components= Preferred Stock; | |||
| 0001999371-25-005991 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Earnings Per Share Diluted | 0.0200 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Increase Decrease In Accounts Payable | -330000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Increase Decrease In Accounts Receivable | 1760000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Increase Decrease In Deferred Revenue | -949000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Increase Decrease In Other Receivables | 55000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 414000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Interest Expense Nonoperating | 218000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Liabilities Noncurrent | 9283000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Net Cash Provided By Used In Financing Activities | 4236000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001999371-25-005991 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Preferred Stock; | |||
| 0001999371-25-005991 | 20250331 | Other Long Term Debt Current | 1000000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Preferred Stock Shares Authorized | 24088.0000 | shares | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Proceeds From Other Short Term Debt | USD | 1 | us-gaap/2025 | ||||
| 0001999371-25-005991 | 20240331 | Repayments Of Other Long Term Debt | 2000000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Repayments Of Related Party Debt | USD | 1 | us-gaap/2025 | ||||
| 0001999371-25-005991 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 9868000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 14575000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Product; | ||
| 0001999371-25-005991 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 50000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Product And Service Other; Timing Of Transfer Of Good Or Service= Transferred Over Time; | ||
| 0001999371-25-005991 | 20240331 | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | USD | 1 | us-gaap/2025 | ||||
| 0001999371-25-005991 | 20250331 | Selling General And Administrative Expense | 2108000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Share Based Compensation | 160000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20231231 | Shares Outstanding | shares | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | |||
| 0001999371-25-005991 | 20241231 | Shares Outstanding | 70103279.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001999371-25-005991 | 20250331 | Shares Outstanding | shares | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | |||
| 0001999371-25-005991 | 20231231 | Stockholders Equity | 106069000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001999371-25-005991 | 20240331 | Stockholders Equity | USD | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | |||
| 0001999371-25-005991 | 20241231 | Stockholders Equity | 14946000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Stockholders Equity | -100428000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001999371-25-005991 | 20250331 | Stockholders Equity | 700000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001999371-25-005991 | 20250331 | Stock Issued During Period Value New Issues | 3000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Stock Issued During Period Value New Issues | 3000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001999371-25-005991 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Accounts Receivable Net Current | 9085000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 296000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 893000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Increase Decrease In Accounts Payable | -654000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Increase Decrease In Accrued Liabilities | 481000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Increase Decrease In Inventories | 3250000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Liabilities Noncurrent | 8984000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Net Cash Provided By Used In Operating Activities | -3855000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Net Income Loss | 893000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001999371-25-005991 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001999371-25-005991 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Proceeds From Issuance Of Convertible Preferred Stock | 6000000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Repayments Of Other Long Term Debt | USD | 1 | us-gaap/2025 | ||||
| 0001999371-25-005991 | 20240331 | Research And Development Expense | 910000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 96000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Product And Service Other; | ||
| 0001999371-25-005991 | 20240331 | Shares Outstanding | 54860984.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001999371-25-005991 | 20240331 | Stockholders Equity | 548000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001999371-25-005991 | 20250331 | Stockholders Equity | -100348000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001999371-25-005991 | 20240229 | Stock Issued During Period Shares New Issues | 15000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Series X Preferred Stock; | ||
| 0001999371-25-005991 | 20250331 | Stock Issued During Period Shares New Issues | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001999371-25-005991 | 20240331 | Stock Issued During Period Value New Issues | 52000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001999371-25-005991 | 20250331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2025 | Equity Components= Preferred Stock; | |||
| 0001999371-25-005991 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 70103279.0000 | shares | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Depreciation Depletion And Amortization | 226000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Income Tax Expense Benefit | USD | 1 | us-gaap/2025 | ||||
| 0001999371-25-005991 | 20241231 | Accounts Receivable Net Current | 4869000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Accrued Liabilities Current | 4849000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Additional Paid In Capital | 114674000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001999371-25-005991 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001999371-25-005991 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001999371-25-005991 | 20241231 | Cash And Cash Equivalents At Carrying Value | 1409000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 408000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Common Stock Shares Issued | 70103279.0000 | shares | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Income Tax Expense Benefit | USD | 1 | us-gaap/2025 | ||||
| 0001999371-25-005991 | 20241231 | Lines Of Credit Inventory Current | 4000000.0000 | USD | 0 | 0001999371-25-005991 | |||
| 0001999371-25-005991 | 20250331 | Net Cash Provided By Used In Operating Activities | -7221000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Net Income Loss | 80000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001999371-25-005991 | 20241231 | Other Long Term Debt Current | 1000000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Preferred Stock Shares Authorized | 24088.0000 | shares | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Proceeds From Lines Of Credit | 200000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 388000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Advanced Materials; | ||
| 0001999371-25-005991 | 20240331 | Stockholders Equity | 108173000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001999371-25-005991 | 20240331 | Stock Issued During Period Value New Issues | 1944000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001999371-25-005991 | 20250331 | Accounts Receivable Gross Current | 10084000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Selling General And Administrative Expense | 1559000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2025 | Equity Components= Preferred Stock; | |||
| 0001999371-25-005991 | 20241231 | Allowance For Doubtful Accounts Receivable Current | 786000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Asset Retirement Obligations Noncurrent | 248000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Assets | 50002000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Capital Expenditures Incurred But Not Yet Paid | 729000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Common Stock Shares Authorized | 95000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Common Stock Shares Issued | 70103279.0000 | shares | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Common Stock Value | 700000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 80000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Interest Paid Net | 160000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Interest Paid Net | 96000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Liabilities Current | 25773000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Net Income Loss | 893000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Preferred Stock; | |||
| 0001999371-25-005991 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001999371-25-005991 | 20250331 | Operating Lease Liability Noncurrent | 8736000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Other Assets Noncurrent | 1000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Preferred Stock Value | USD | 0 | us-gaap/2025 | ||||
| 0001999371-25-005991 | 20250331 | Prepaid Expense And Other Assets Current | 3090000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Property Plant And Equipment Net | 12734000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Retained Earnings Accumulated Deficit | -100428000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 370000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Advanced Materials; | ||
| 0001999371-25-005991 | 20250331 | Share Based Compensation | 127000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Shares Outstanding | shares | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | |||
| 0001999371-25-005991 | 20231231 | Stockholders Equity | 1902000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20231231 | Stockholders Equity | USD | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | |||
| 0001999371-25-005991 | 20250331 | Stockholders Equity | 15156000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Stockholders Equity | USD | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | |||
| 0001999371-25-005991 | 20250331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001999371-25-005991 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 58035741.0000 | shares | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Assets Current | 29348000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 2018000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Deferred Revenue Current | 5571000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Earnings Per Share Basic | 0.0200 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Gross Profit | 3382000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Increase Decrease In Accrued Liabilities | 419000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Increase Decrease In Inventories | 1645000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Increase Decrease In Other Receivables | USD | 1 | us-gaap/2025 | ||||
| 0001999371-25-005991 | 20241231 | Inventory Net | 20267000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Liabilities And Stockholders Equity | 50002000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Liabilities And Stockholders Equity | 57016000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001999371-25-005991 | 20250331 | Operating Lease Liability Current | 1328000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20241231 | Operating Lease Liability Noncurrent | 9037000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Proceeds From Issuance Of Common Stock | 4000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Proceeds From Lines Of Credit | 1200000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20250331 | Retained Earnings Accumulated Deficit | -100348000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 8104000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Consumer Products; | ||
| 0001999371-25-005991 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 96000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Product And Service Other; Timing Of Transfer Of Good Or Service= Transferred Over Time; | ||
| 0001999371-25-005991 | 20250331 | Shares Outstanding | 70103279.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001999371-25-005991 | 20240331 | Stockholders Equity | 4951000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Stock Issued During Period Value New Issues | 1996000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005991 | 20240331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2025 | Equity Components= Preferred Stock; | |||
| 0001999371-25-005991 | 20240331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Operating Lease Liability Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Proceeds From Issuance Of Convertible Preferred Stock | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Convertible Preferred Stock | The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Investing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash and Cash Equivalent | Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Common Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Earnings Per Share Diluted | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Proceeds From Issuance Of Common Stock | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
| Property Plant And Equipment Net | us-gaap/2025 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation | Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Increase Decrease In Operating Lease Liability | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Lines Of Credit Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Line of Credit, Current | The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement. |
| Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Excluding Assessed Tax | Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2025 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Selling General And Administrative Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Selling, General and Administrative Expense | The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. |
| Additional Paid In Capital | us-gaap/2025 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Increase Decrease In Accounts Payable | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Accrued Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Depreciation Depletion And Amortization | us-gaap/2025 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2025 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Liabilities Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities, Noncurrent | Amount of obligation due after one year or beyond the normal operating cycle, if longer. |
| Operating Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Research And Development Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Accounts Receivable Net Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Operating Lease Liability Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Operating Lease Right Of Use Asset | us-gaap/2025 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Proceeds From Lines Of Credit | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Lines of Credit | Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements. |
| Proceeds From Other Short Term Debt | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Other Short-Term Debt | Amount of cash inflow from short-term debt classified as other. |
| Earnings Per Share Basic | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Accounts Receivable Gross Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Accounts Receivable, before Allowance for Credit Loss, Current | Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Asset Retirement Obligations Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Asset Retirement Obligations, Noncurrent | Noncurrent portion of the carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Preferred Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Repayments Of Other Long Term Debt | us-gaap/2025 | 0 | 0 | monetary | D | C | Repayments of Other Long-Term Debt | Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer. |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | us-gaap/2025 | 0 | 0 | monetary | D | D | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | Amount of increase in right-of-use asset obtained in exchange for operating lease liability. |
| Stock Issued During Period Shares New Issues | us-gaap/2025 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Lines Of Credit Inventory Current | 0001999371-25-005991 | 1 | 0 | monetary | I | C | Line of credit inventory, related party | The element represents lines of credit inventory current. |
| Increase Decrease In Inventories | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
| Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Financing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit. |
| Common Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Other Assets Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Assets | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Increase Decrease In Accounts Receivable | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Liabilities And Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Net Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Deferred Revenue Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Deferred Revenue, Current | Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current. |
| Increase Decrease In Other Receivables | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Receivables | Amount of increase (decrease) in receivables classified as other. |
| Interest Expense Nonoperating | us-gaap/2025 | 0 | 0 | monetary | D | D | Interest Expense, Nonoperating | Amount of interest expense classified as nonoperating. |
| Prepaid Expense And Other Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Gross Profit | us-gaap/2025 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
| Income Tax Expense Benefit | us-gaap/2025 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Inventory Net | us-gaap/2025 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
| Capital Expenditures Incurred But Not Yet Paid | us-gaap/2025 | 0 | 0 | monetary | D | C | Capital Expenditures Incurred but Not yet Paid | Future cash outflow to pay for purchases of fixed assets that have occurred. |
| Increase Decrease In Accrued Liabilities | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Interest Paid Net | us-gaap/2025 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activity | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Payments For Proceeds From Productive Assets | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments for (Proceeds from) Productive Assets | The net cash outflow or inflow from purchases, sales and disposals of property, plant and equipment and other productive assets, including intangibles. |
| Preferred Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Repayments Of Related Party Debt | us-gaap/2025 | 0 | 0 | monetary | D | C | Repayments of Related Party Debt | The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates. |
| Share Based Compensation | us-gaap/2025 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Accounts Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Increase Decrease In Deferred Revenue | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Deferred Revenue | Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable. |
| Other Long Term Debt Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Other Long-Term Debt, Current | Amount of long-term debt classified as other, payable within one year or the operating cycle, if longer. |
| Preferred Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Cost Of Goods And Services Sold | us-gaap/2025 | 0 | 0 | monetary | D | D | Cost of Product and Service Sold | The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2025 | 0 | 0 | monetary | D | Cash Provided by (Used in) Operating Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. | |
| Retained Earnings Accumulated Deficit | us-gaap/2025 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Stock Issued During Period Value New Issues | us-gaap/2025 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Allowance For Doubtful Accounts Receivable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accounts Receivable, Allowance for Credit Loss, Current | Amount of allowance for credit loss on accounts receivable, classified as current. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001999371-25-005991 | 5 | 15 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Ending balance | 0 |
| 0001999371-25-005991 | 5 | 16 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Ending balance (in shares) | 0 |
| 0001999371-25-005991 | 2 | 31 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2025 | Accumulated deficit | 0 |
| 0001999371-25-005991 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | Cash | 0 |
| 0001999371-25-005991 | 2 | 4 | BS | 0 | H | Accounts Receivable Gross Current | us-gaap/2025 | Trade accounts receivable | 0 |
| 0001999371-25-005991 | 2 | 5 | BS | 0 | H | Allowance For Doubtful Accounts Receivable Current | us-gaap/2025 | Allowance for credit losses | 1 |
| 0001999371-25-005991 | 2 | 6 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2025 | Trade accounts receivable, net | 0 |
| 0001999371-25-005991 | 2 | 7 | BS | 0 | H | Inventory Net | us-gaap/2025 | Inventories, net | 0 |
| 0001999371-25-005991 | 2 | 8 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2025 | Prepaid expenses and other current assets | 0 |
| 0001999371-25-005991 | 2 | 9 | BS | 0 | H | Assets Current | us-gaap/2025 | Total current assets | 0 |
| 0001999371-25-005991 | 2 | 10 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2025 | Equipment and leasehold improvements, net | 0 |
| 0001999371-25-005991 | 2 | 11 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2025 | Operating leases, right of use | 0 |
| 0001999371-25-005991 | 2 | 12 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2025 | Other assets, net | 0 |
| 0001999371-25-005991 | 2 | 13 | BS | 0 | H | Assets | us-gaap/2025 | Total assets | 0 |
| 0001999371-25-005991 | 2 | 16 | BS | 0 | H | Lines Of Credit Current | us-gaap/2025 | Line of credit accounts receivable, related party | 0 |
| 0001999371-25-005991 | 2 | 17 | BS | 0 | H | Lines Of Credit Inventory Current | 0001999371-25-005991 | Line of credit inventory, related party | 0 |
| 0001999371-25-005991 | 2 | 18 | BS | 0 | H | Other Long Term Debt Current | us-gaap/2025 | Term debt, related party | 0 |
| 0001999371-25-005991 | 2 | 19 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2025 | Current portion of operating lease obligations | 0 |
| 0001999371-25-005991 | 2 | 20 | BS | 0 | H | Accounts Payable Current | us-gaap/2025 | Accounts payable | 0 |
| 0001999371-25-005991 | 2 | 21 | BS | 0 | H | Deferred Revenue Current | us-gaap/2025 | Deferred revenue | 0 |
| 0001999371-25-005991 | 2 | 22 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2025 | Accrued expenses | 0 |
| 0001999371-25-005991 | 2 | 23 | BS | 0 | H | Liabilities Current | us-gaap/2025 | Total current liabilities | 0 |
| 0001999371-25-005991 | 2 | 24 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2025 | Long-term portion of operating lease obligations | 0 |
| 0001999371-25-005991 | 2 | 25 | BS | 0 | H | Asset Retirement Obligations Noncurrent | us-gaap/2025 | Asset retirement obligations | 0 |
| 0001999371-25-005991 | 2 | 26 | BS | 0 | H | Liabilities Noncurrent | us-gaap/2025 | Total long-term liabilities | 0 |
| 0001999371-25-005991 | 2 | 28 | BS | 0 | H | Preferred Stock Value | us-gaap/2025 | Preferred stock, $.01 par value, 24,088 shares authorized, and no shares issued and outstanding | 0 |
| 0001999371-25-005991 | 2 | 29 | BS | 0 | H | Common Stock Value | us-gaap/2025 | Common stock, $.01 par value, 95,000,000 shares authorized; 70,103,279 shares issued and outstanding on March 31, 2025 and December 31 2024, respectively | 0 |
| 0001999371-25-005991 | 2 | 30 | BS | 0 | H | Additional Paid In Capital | us-gaap/2025 | Additional paid-in capital | 0 |
| 0001999371-25-005991 | 2 | 32 | BS | 0 | H | Stockholders Equity | us-gaap/2025 | Total stockholders equity | 0 |
| 0001999371-25-005991 | 2 | 33 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2025 | Total liabilities and stockholders equity | 0 |
| 0001999371-25-005991 | 3 | 1 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2025 | Preferred stock, par value (in dollars per share) | 0 |
| 0001999371-25-005991 | 3 | 2 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2025 | Preferred stock, authorized | 0 |
| 0001999371-25-005991 | 3 | 3 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2025 | Preferred stock, issued | 0 |
| 0001999371-25-005991 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2025 | Preferred stock, outstanding | 0 |
| 0001999371-25-005991 | 3 | 5 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2025 | Common stock, par value (in dollars per share) | 0 |
| 0001999371-25-005991 | 3 | 6 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2025 | Common stock, authorized | 0 |
| 0001999371-25-005991 | 3 | 7 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2025 | Common stock, issued | 0 |
| 0001999371-25-005991 | 3 | 8 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2025 | Common stock, outstanding | 0 |
| 0001999371-25-005991 | 4 | 7 | IS | 0 | H | Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2025 | Total revenue | 0 |
| 0001999371-25-005991 | 4 | 9 | IS | 0 | H | Cost Of Goods And Services Sold | us-gaap/2025 | Cost of revenue | 0 |
| 0001999371-25-005991 | 4 | 10 | IS | 0 | H | Gross Profit | us-gaap/2025 | Gross profit | 0 |
| 0001999371-25-005991 | 4 | 11 | IS | 0 | H | Research And Development Expense | us-gaap/2025 | Research and development expense | 0 |
| 0001999371-25-005991 | 4 | 12 | IS | 0 | H | Selling General And Administrative Expense | us-gaap/2025 | Selling, general and administrative expense | 0 |
| 0001999371-25-005991 | 4 | 13 | IS | 0 | H | Operating Income Loss | us-gaap/2025 | Net income from operations | 0 |
| 0001999371-25-005991 | 4 | 14 | IS | 0 | H | Interest Expense Nonoperating | us-gaap/2025 | Interest expense | 0 |
| 0001999371-25-005991 | 4 | 15 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2025 | Net income before provision for income taxes | 0 |
| 0001999371-25-005991 | 4 | 16 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2025 | Provision for income taxes | 0 |
| 0001999371-25-005991 | 4 | 17 | IS | 0 | H | Net Income Loss | us-gaap/2025 | Net income | 0 |
| 0001999371-25-005991 | 4 | 18 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2025 | Net income (loss) per share-basic | 0 |
| 0001999371-25-005991 | 4 | 19 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | Weighted average number of basic common shares outstanding | 0 |
| 0001999371-25-005991 | 4 | 20 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2025 | Net income (loss) per share-diluted | 0 |
| 0001999371-25-005991 | 4 | 21 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2025 | Weighted average number of diluted common shares outstanding | 0 |
| 0001999371-25-005991 | 5 | 9 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Beginning balance | 0 |
| 0001999371-25-005991 | 5 | 10 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Beginning balance (in shares) | 0 |
| 0001999371-25-005991 | 5 | 11 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2025 | Issuance of shares and stock option exercises | 0 |
| 0001999371-25-005991 | 5 | 12 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2025 | Issuances of shares and stock option exercises (in shares) | 0 |
| 0001999371-25-005991 | 5 | 13 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2025 | Stock-based compensation | 0 |
| 0001999371-25-005991 | 5 | 14 | EQ | 0 | H | Net Income Loss | us-gaap/2025 | Net income | 0 |
| 0001999371-25-005991 | 6 | 4 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2025 | Depreciation and amortization | 0 |
| 0001999371-25-005991 | 6 | 5 | CF | 0 | H | Share Based Compensation | us-gaap/2025 | Stock-based compensation | 0 |
| 0001999371-25-005991 | 6 | 7 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2025 | Trade accounts receivable, net | 1 |
| 0001999371-25-005991 | 6 | 8 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2025 | Inventories, net | 1 |
| 0001999371-25-005991 | 6 | 9 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | Prepaid expenses and other assets | 1 |
| 0001999371-25-005991 | 6 | 10 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2025 | Accounts payable | 0 |
| 0001999371-25-005991 | 6 | 11 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2025 | Accrued expenses | 0 |
| 0001999371-25-005991 | 6 | 12 | CF | 0 | H | Increase Decrease In Deferred Revenue | us-gaap/2025 | Deferred revenue | 0 |
| 0001999371-25-005991 | 6 | 13 | CF | 0 | H | Increase Decrease In Other Receivables | us-gaap/2025 | Other receivables | 1 |
| 0001999371-25-005991 | 6 | 14 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2025 | Change in right of use asset and lease liability, net | 0 |
| 0001999371-25-005991 | 6 | 15 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2025 | Net cash used in operating activities | 0 |
| 0001999371-25-005991 | 6 | 17 | CF | 0 | H | Payments For Proceeds From Productive Assets | us-gaap/2025 | Acquisition of equipment and leasehold improvements | 1 |
| 0001999371-25-005991 | 6 | 18 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2025 | Net cash used in investing activities | 0 |
| 0001999371-25-005991 | 6 | 20 | CF | 0 | H | Proceeds From Lines Of Credit | us-gaap/2025 | Proceeds from line of credit - inventory, related party | 0 |
| 0001999371-25-005991 | 6 | 21 | CF | 0 | H | Proceeds From Other Short Term Debt | us-gaap/2025 | Proceeds from line of credit accounts receivable, related party | 0 |
| 0001999371-25-005991 | 6 | 22 | CF | 0 | H | Repayments Of Related Party Debt | us-gaap/2025 | Payments to line of credit accounts receivable, related party | 1 |
| 0001999371-25-005991 | 6 | 23 | CF | 0 | H | Repayments Of Other Long Term Debt | us-gaap/2025 | Payments to term loans, related party | 1 |
| 0001999371-25-005991 | 6 | 24 | CF | 0 | H | Proceeds From Issuance Of Convertible Preferred Stock | us-gaap/2025 | Proceeds from issuance of mezzanine preferred stock | 0 |
| 0001999371-25-005991 | 6 | 25 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2025 | Proceeds from issuance of stock and exercise of stock options | 0 |
| 0001999371-25-005991 | 6 | 26 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2025 | Net cash provided by financing activities | 0 |
| 0001999371-25-005991 | 6 | 27 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2025 | Increase in cash | 0 |
| 0001999371-25-005991 | 6 | 28 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash at beginning of period | 0 |
| 0001999371-25-005991 | 6 | 29 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash at end of period | 0 |
| 0001999371-25-005991 | 6 | 31 | CF | 0 | H | Interest Paid Net | us-gaap/2025 | Interest paid | 0 |
| 0001999371-25-005991 | 6 | 33 | CF | 0 | H | Capital Expenditures Incurred But Not Yet Paid | us-gaap/2025 | Accounts payable incurred for the purchase of equipment and leasehold improvements | 0 |
| 0001999371-25-005991 | 6 | 34 | CF | 0 | H | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | us-gaap/2025 | Right-of-use asset obtained in exchange for a lease liability | 0 |
| 0001999371-25-005991 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2025 | Net income | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |